International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial – Associated Press

International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson’s Disease Clinical Trial – Associated Press
International Stem Cell Corporation Completes Enrollment and Dosing in its Parkinson's Disease Clinical Trial  Associated PressPress release *content* from Globe Newswire. The AP news staff was not involved in its creation. ... read more
Source: Google NewsPublished on 2019-04-29